Dexcom's 2024 Nasdaq 100 Performance Lags
Discover why Dexcom's stock underperformed in the Nasdaq 100 for 2024. Explore insights, trends, and factors impacting Dexcom's market position.
Topic
2024
A collection of 345 issues
Microchip Technology's Nasdaq 100 Struggles in 2024
Explore why Microchip Technology ranked among the worst performers on Nasdaq 100 in 2024. Discover insights into the company's financial challenges and market trends.
Biogen's Struggles on Nasdaq 100 in 2024
Discover why Biogen plummeted as one of the worst-performing stocks on Nasdaq 100 in 2024. Explore the factors impacting its market performance.
Nasdaq 100 Surges 25% in 2024 Amid AI Focus
Nasdaq 100 gains 25% in 2024 as AI-driven investments take the lead, posing challenges for traditional non-AI sectors.
Mubadala Boosts 2024 Investments with $29.2 Billion Deployment
Discover how Mubadala Investment Co. dramatically increased its investment activities in 2024, deploying a substantial $29.2 billion into global ventures.
GIC and Temasek Boost Investments in 2024
Explore how Singapore's GIC and Temasek ramped up their investment activities in 2024 after a significant cutback in 2023. Discover the impact on global markets.
Mubadala Leads Global Sovereign Wealth Investments in 2024
Discover how Abu Dhabi’s Mubadala Investment Co. emerged as the top sovereign wealth fund in 2024 with a $29.2 billion investment spree, a 67% year-over-year surge.
Axon Shines as Nasdaq 100 Top Performer in 2024
Discover how Axon emerged as a standout performer in the Nasdaq 100 for 2024, marking a successful year for the newcomer. Learn about its journey and impact.
Palantir Shines as Top Nasdaq 100 Performer in 2024
Discover how Palantir emerged as a top performer in 2024 after joining the Nasdaq 100. Learn about its impressive growth and market impact.
Nasdaq 100 Surges 25% in 2024, Setting Record Highs
Explore the Nasdaq 100's impressive 25% rise in 2024, reaching multiple record highs. Stay informed about stock market trends and investment opportunities.